CA2683786C - Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects - Google Patents

Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects Download PDF

Info

Publication number
CA2683786C
CA2683786C CA2683786A CA2683786A CA2683786C CA 2683786 C CA2683786 C CA 2683786C CA 2683786 A CA2683786 A CA 2683786A CA 2683786 A CA2683786 A CA 2683786A CA 2683786 C CA2683786 C CA 2683786C
Authority
CA
Canada
Prior art keywords
tapentadol
pain
treatment
effects
reduced incidence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2683786A
Other languages
English (en)
French (fr)
Other versions
CA2683786A1 (en
Inventor
Claudia Lange
Ferdinand Rombout
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38123877&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CA2683786(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CA2683786A1 publication Critical patent/CA2683786A1/en
Application granted granted Critical
Publication of CA2683786C publication Critical patent/CA2683786C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Adhesive Tapes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA2683786A 2007-04-23 2008-04-21 Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects Active CA2683786C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07008218A EP1985292A1 (en) 2007-04-23 2007-04-23 Titration of tapentadol
EP07008218.5 2007-04-23
PCT/EP2008/003178 WO2008128740A1 (en) 2007-04-23 2008-04-21 Titration of tapentadol

Publications (2)

Publication Number Publication Date
CA2683786A1 CA2683786A1 (en) 2008-10-30
CA2683786C true CA2683786C (en) 2021-10-26

Family

ID=38123877

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2683786A Active CA2683786C (en) 2007-04-23 2008-04-21 Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects

Country Status (21)

Country Link
US (4) US20090012180A1 (https=)
EP (5) EP1985292A1 (https=)
JP (4) JP5933176B2 (https=)
KR (3) KR102078999B1 (https=)
CN (1) CN101730530B (https=)
AT (1) ATE534378T1 (https=)
AU (1) AU2008241013B2 (https=)
CA (1) CA2683786C (https=)
CY (1) CY1112320T1 (https=)
DK (1) DK2148670T3 (https=)
ES (1) ES2378255T3 (https=)
HR (1) HRP20120147T1 (https=)
IL (1) IL201479A (https=)
MX (1) MX2009011444A (https=)
NZ (1) NZ580415A (https=)
PL (1) PL2148670T3 (https=)
PT (1) PT2148670E (https=)
RU (1) RU2472497C2 (https=)
SI (1) SI2148670T1 (https=)
WO (1) WO2008128740A1 (https=)
ZA (1) ZA200907355B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1985292A1 (en) 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol
RU2673882C1 (ru) * 2008-10-30 2018-12-03 Грюненталь Гмбх Новые и эффективные лекарственные формы тапентадола
US8870876B2 (en) * 2009-02-13 2014-10-28 Tarsus Medical Inc. Methods and devices for treating hallux valgus
US8277459B2 (en) * 2009-09-25 2012-10-02 Tarsus Medical Inc. Methods and devices for treating a structural bone and joint deformity
US8652141B2 (en) 2010-01-21 2014-02-18 Tarsus Medical Inc. Methods and devices for treating hallux valgus
EP2566461A2 (de) * 2010-05-05 2013-03-13 Ratiopharm GmbH Festes tapentadol in nicht-kristalliner form
US8696719B2 (en) 2010-06-03 2014-04-15 Tarsus Medical Inc. Methods and devices for treating hallux valgus
DK2588093T3 (en) * 2010-06-30 2016-08-29 Gruenenthal Gmbh Tapentadol FOR USE IN THE TREATMENT OF irritable bowel syndrome
CN110015955A (zh) * 2010-07-23 2019-07-16 格吕伦塔尔有限公司 3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的盐或共晶体
CN101948397A (zh) * 2010-09-07 2011-01-19 天津泰普药品科技发展有限公司 镇痛药他喷他多重要中间体的制备方法
ES2910085T3 (es) 2011-03-04 2022-05-11 Gruenenthal Gmbh Composición farmacéutica acuosa semisólida que contiene tapentadol
CN103501775A (zh) * 2011-03-04 2014-01-08 格吕伦塔尔有限公司 他喷他多的胃肠外给药
MX388963B (es) 2011-03-04 2025-03-20 Gruenenthal Gmbh Formulacion farmaceutica acuosa de tapentadol para administracion oral
EP3607943B1 (en) * 2011-04-05 2024-09-11 Grünenthal GmbH Tapentadol for use in treating pain associated with trigeminal neuralgia
ES2703282T3 (es) 2011-04-05 2019-03-07 Gruenenthal Gmbh Tapentadol para prevenir la cronificación del dolor
US20120277319A1 (en) 2011-04-29 2012-11-01 Gruenenthal Gmbh Use of Tapentadol for Inhibiting and/or Treating Depression and Anxiety
CA2901802C (en) * 2013-03-15 2021-03-02 Mallinckrodt Llc Abuse deterrent solid dosage form for immediate release with functional score
EP2845625A1 (en) * 2013-09-04 2015-03-11 Grünenthal GmbH Tapentadol for use in the treatment of fibromyalgia and chronic fatigue syndrome
PE20171651A1 (es) 2015-03-27 2017-11-13 Gruenenthal Chemie Formulacion estable para administracion parenteral de tapentadol
PT3302454T (pt) * 2015-05-26 2021-04-01 Technophage Investig E Desenvolvimento Em Biotecnologia Sa Composições para utilização no tratamento da doença de parkinson e distúrbios associados
JP7373904B2 (ja) * 2016-02-29 2023-11-06 パーク・セラピューティクス・インコーポレイテッド セブラノパドールの滴定
EP3515412B1 (en) 2016-09-23 2025-04-23 Grünenthal GmbH Stable formulation for parenteral administration of tapentadol
ES3010208T3 (en) 2020-03-16 2025-04-01 Gruenenthal Gmbh Scored tablet comprising tapentadol
WO2022194941A1 (en) * 2021-03-17 2022-09-22 Actelion Pharmaceuticals Ltd Pharmaceutical dosage system
EP4333820A1 (en) * 2021-05-07 2024-03-13 Grünenthal GmbH Tapentadol for treating neuropathic pain in covid-19 patients

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4783337A (en) 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4612008A (en) * 1983-05-11 1986-09-16 Alza Corporation Osmotic device with dual thermodynamic activity
US4765989A (en) 1983-05-11 1988-08-23 Alza Corporation Osmotic device for administering certain drugs
JPS6327805A (ja) 1986-07-21 1988-02-05 Sumitomo Electric Ind Ltd 光フアイバの接続用部材及びそれを用いた接続方法
DE4426245A1 (de) * 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
US6339105B1 (en) * 1999-10-12 2002-01-15 Ortho-Mcneil Pharmaceutical, Inc. Analgesic regimen
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
DK1572167T3 (da) 2002-12-13 2008-10-13 Euro Celtique Sa Transdermal buprenophindoseringsbehandlingsplan for analgesi
US7413749B2 (en) * 2003-03-11 2008-08-19 Purdue Pharma L.P. Titration dosing regimen for controlled release tramadol
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP1985292A1 (en) * 2007-04-23 2008-10-29 Grünenthal GmbH Titration of tapentadol

Also Published As

Publication number Publication date
CY1112320T1 (el) 2015-12-09
KR102078999B1 (ko) 2020-02-19
MX2009011444A (es) 2009-11-05
IL201479A (en) 2016-04-21
US20090012180A1 (en) 2009-01-08
JP5933176B2 (ja) 2016-06-08
WO2008128740A8 (en) 2010-06-17
CN101730530B (zh) 2013-10-23
AU2008241013B2 (en) 2013-06-20
RU2009142940A (ru) 2011-05-27
EP2148670B1 (en) 2011-11-23
IL201479A0 (en) 2010-05-31
JP2018030864A (ja) 2018-03-01
EP3603630A1 (en) 2020-02-05
ZA200907355B (en) 2010-08-25
KR20150027840A (ko) 2015-03-12
US20160074342A1 (en) 2016-03-17
SI2148670T1 (sl) 2012-03-30
RU2472497C2 (ru) 2013-01-20
EP3143993A1 (en) 2017-03-22
WO2008128740A1 (en) 2008-10-30
JP2019131598A (ja) 2019-08-08
AU2008241013A1 (en) 2008-10-30
EP2422778A1 (en) 2012-02-29
US20190290603A1 (en) 2019-09-26
ES2378255T3 (es) 2012-04-10
NZ580415A (en) 2012-04-27
KR20180004839A (ko) 2018-01-12
PT2148670E (pt) 2012-01-24
CA2683786A1 (en) 2008-10-30
CN101730530A (zh) 2010-06-09
JP2010531296A (ja) 2010-09-24
EP1985292A1 (en) 2008-10-29
PL2148670T3 (pl) 2012-04-30
KR20100017267A (ko) 2010-02-16
US11344512B2 (en) 2022-05-31
DK2148670T3 (da) 2012-03-12
ATE534378T1 (de) 2011-12-15
JP2016128468A (ja) 2016-07-14
HRP20120147T1 (hr) 2012-03-31
EP2148670A1 (en) 2010-02-03
HK1140940A1 (en) 2010-10-29
US20170079938A1 (en) 2017-03-23

Similar Documents

Publication Publication Date Title
CA2683786C (en) Use of tapentadol in the treatment of pain and with a reduced incidence of tapentadol-induced side-effects
UA105210C2 (ru) Противораковая вакцина и ее применение
WO2007012022A3 (en) Unit dose form with ibuprofen-famotidine admixture
WO2008040534A3 (en) Non-mucoadhesive film dosage forms
MX2009002196A (es) Oblea de buprenorfina para terapia de sustitucion de farmacos.
PH12013501790B1 (en) Use of dpp iv inhibitors
WO2008085765A3 (en) Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
WO2008027449A3 (en) Methods, compositions and apparatuses to treat wounds with pressures altered from atmospheric
NZ707377A (en) Combination therapy methods for treating proliferative diseases
MY153408A (en) Novel methods
MX2020009811A (es) Tratamiento de la diabetes en pacientes con control glucemico insuficiente a pesar de la terapia con un farmaco oral o no oral antidiabetico.
MY159353A (en) Pirfenidone treatment for patients with atypical liver function
NZ628513A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
EP2216024A3 (en) Use of Ranolazine for the treatment of cardiovascular diseases
WO2012063134A3 (en) Cardiac glycoside analogs in combination with emodin for cancer therapy
MX2009011900A (es) Curacion de herida diabetica.
WO2008045378A3 (en) Treatment of infant hyperbilirubinemia using low dosages of stannsoporfin
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
WO2007133796A3 (en) Methods and compositions for treatment of sleep apnea comprising administration of an endothelin antagonist
MX2009008108A (es) Composicion farmaceutica que contiene una combinacion de tramadol y ketoprofeno.
MY164112A (en) A combination composition comprising ibuprofen and paracetamol
MX2009008813A (es) Composicion farmaceutica que contiene floroglucinol y paracetamol.
EA200801890A1 (ru) Средство для лечения шума в ушах
IL218069A (en) Oligoscride compounds, drug, pharmaceutical, and compound for its use in therapy
WO2005116210A3 (de) Sirna und shrna gegen stat6 zur behandlung allergischer erkrankungen, pathologischer atemwegsveränderungen und von krebs

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20130402

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: A-4-4-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20251022

H13 Ip right lapsed

Free format text: ST27 STATUS EVENT CODE: N-4-6-H10-H13-H100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE AND LATE FEE NOT PAID BY DEADLINE OF NOTICE

Effective date: 20260203

W00 Other event occurred

Free format text: ST27 STATUS EVENT CODE: N-6-6-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT

Effective date: 20260209